Clinical trial
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in…
NCT00037661 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00037661 |
|---|---|
| Title | Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye |
| Official title | Double-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Keratoconjunctivitis Sicca |
| Intervention type | Drug |
| Interventions | INS365 Ophthalmic Solution |
| Enrollment | 222 |
| Start date | Apr 1, 2002 |
| Primary completion | Mar 1, 2003 |
| Completion | Mar 1, 2003 |
| First posted | May 20, 2002 |
| Last update posted | Oct 2, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: